Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H18N2O2 |
Molecular Weight | 246.3049 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCNC(=O)C1=C(OCC#C)C=CC(N)=C1
InChI
InChIKey=DXHYQIJBUNRPJT-UHFFFAOYSA-N
InChI=1S/C14H18N2O2/c1-3-5-8-16-14(17)12-10-11(15)6-7-13(12)18-9-4-2/h2,6-7,10H,3,5,8-9,15H2,1H3,(H,16,17)
Molecular Formula | C14H18N2O2 |
Molecular Weight | 246.3049 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis of substituted benzamides as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 but do not cause gastric damage. | 2001 Jun |
|
In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives. | 2006 Mar |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11525842
Parsalmide inhibited purified ovine COX-1 and COX-2 in vitro with IC50 9.92 uM 155 uM, respectively.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:50:06 GMT 2023
by
admin
on
Sat Dec 16 17:50:06 GMT 2023
|
Record UNII |
YQH5093J7C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3418
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
C66326
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
m1220
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID80865553
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107094
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
SUB09633MIG
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
72095
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
C100267
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
YQH5093J7C
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
250-274-2
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
30653-83-9
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
3628
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY | |||
|
100000082999
Created by
admin on Sat Dec 16 17:50:06 GMT 2023 , Edited by admin on Sat Dec 16 17:50:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |